Pacific Biosciences

Pacific Biosciences PACB Stock

$1.96   -0.507614%
Add to favorites
Market Cap
$611.98M
LOW - HIGH [24H]
$1.84 - $2.00
VOLUME [24H]
$7.02M
P/E Ratio
0
Earnings per share
-$0.42
ISIN
US69404D1081
Price   Prediction

Pacific Biosciences Price Chart

Sorry, that's all we've gotfor now...

Pacific Biosciences (PACB) stock price today is 1.96 USD on Tech Market Large (-0.51% on the day). Updated .

Pacific Biosciences PACB Financial and Trading Overview

Pacific Biosciences stock price 1.96 USD
Previous Close 1.97 USD
Open 1.99 USD
Bid 1.8 USD x 5000
Ask 1.96 USD x 1700
Day's Range 1.84 - 2 USD
52 Week Range 1.07 - 3.44 USD
Volume 7.02M USD
Avg. Volume 12.55M USD
Market Cap 611.98M USD
Beta (5Y Monthly) 2.202
PE Ratio (TTM) N/A
EPS (TTM) -0.42 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 2.74 USD

PACB Valuation Measures

Enterprise Value 1.12B USD
Trailing P/E N/A
Forward P/E -4.885344
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.7918646
Price/Book (mrq) N/A
Enterprise Value/Revenue 6.954
Enterprise Value/EBITDA -6.873

Trading Information

Pacific Biosciences Stock Price History

Beta (5Y Monthly) 2.202
52-Week Change 24.84%
S&P500 52-Week Change 13.32%
52 Week High 3.44 USD
52 Week Low 1.07 USD
50-Day Moving Average 2.01 USD
200-Day Moving Average 1.6 USD

PACB Share Statistics

Avg. Volume (3 month) 12.55M USD
Avg. Daily Volume (10-Days) 11.52M USD
Shares Outstanding 312.24M
Float 306.23M
Short Ratio 2.66
% Held by Insiders 8.96%
% Held by Institutions 67.21%
Shares Short 53.68M
Short % of Float 19.75%
Short % of Shares Outstanding 17.19%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -81.31%
Operating Margin (ttm) -332.99%
Gross Margin 27.67%
EBITDA Margin -101.18%

Management Effectiveness

Return on Assets (ttm) -44.073%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 161.39M USD
Revenue Per Share (ttm) 0.53 USD
Quarterly Revenue Growth (yoy) 5.50%
Gross Profit (ttm) 44.66M USD
EBITDA -163300992 USD
Net Income Avi to Common (ttm) -131233000 USD
Diluted EPS (ttm) -0.42
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 199.42M USD
Total Cash Per Share (mrq) 0.64 USD
Total Debt (mrq) 708.37M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 4.623
Book Value Per Share (mrq) -0.197

Cash Flow Statement

Operating Cash Flow (ttm) -136948000 USD
Levered Free Cash Flow (ttm) 44.06M USD

Profile of Pacific Biosciences

Country United States
State CA
City Menlo Park
Address 1305 O’Brien Drive
ZIP 94025
Phone 650 521 8000
Website https://www.pacb.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 485

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, and Sequel instruments which conduct, monitor, and analyze single-molecule biochemical reactions on SMRT cell microchips; short-read sequencing; and onso instrument. It serves academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. It has a collaboration with DNAstack Inc. to provide federated dataset of HiFi whole genome sequencing data. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Q&A For Pacific Biosciences Stock

What is a current PACB stock price?

Pacific Biosciences PACB stock price today per share is 1.96 USD.

How to purchase Pacific Biosciences stock?

You can buy PACB shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pacific Biosciences?

The stock symbol or ticker of Pacific Biosciences is PACB.

Which industry does the Pacific Biosciences company belong to?

The Pacific Biosciences industry is Medical Devices.

How many shares does Pacific Biosciences have in circulation?

The max supply of Pacific Biosciences shares is 312.24M.

What is Pacific Biosciences Price to Earnings Ratio (PE Ratio)?

Pacific Biosciences PE Ratio is now.

What was Pacific Biosciences earnings per share over the trailing 12 months (TTM)?

Pacific Biosciences EPS is -0.42 USD over the trailing 12 months.

Which sector does the Pacific Biosciences company belong to?

The Pacific Biosciences sector is Healthcare.

Pacific Biosciences PACB included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 25136.27 USD —
-0.91
7.74B USD — 24872.41 USD — 25423.09 USD — — 7.74B USD —
us US Tech Biotechnology Total Retu XNBI US 7879.89 USD —
-0.49
— — 7812.06 USD — 7910.07 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 3020.37 USD —
-0.22
— — 2991.33 USD — 3035.56 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3748.08 USD —
-0.7
— — 3701.51 USD — 3782.39 USD — — — —
us US Tech Biotechnology NBI US 7211.27 USD —
-0.5
— — 7149.19 USD — 7238.9 USD — — — —
us US Tech Health Care IXHC US 1368.29 USD —
-0.34
— — 1358.68 USD — 1373.65 USD — — — —
us US Tech Composite Total Return XCMP US 31061.46 USD —
-0.9
— — 30735.41 USD — 31415.87 USD — — — —
us US Tech Global Select Market Com NQGS US 12378.66 USD —
-0.9
— — 12248.6 USD — 12520.36 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.2T
Total marketcap
$73.14B
Total volume
BTC 59.41%   •   ETH 10.11%
Dominance
Select currency